glp 1 agonist oral New GLP-1 Guidelines for Type 2 Diabetes in 2025 Orforglipron, an Oral Small-Molecule GLP-1
Description
doi: 10.1016/j.ophtha.2006.10.023 [DOI] [PubMed] [Google Scholar] 16.Xu J, Xu L, Wang YX, You QS, Jonas JB, Wei WB
We did not include any case reports, abstracts without full texts, and works that did not focus on the relevant therapeutic agents or pain models
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
doi: 10.2337/db18-0155 77 Gonzalez-PerezASchliengerRGRodrguezLA
Trevaskis, J
